Home > PS Ratio > KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES
PS (Price/Sales) Ratio

The Current P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES is 5.41.

Share Price ₹59.4Jul 03,2026
Market Cap ₹128.3 Cr
Sales-TTM₹23.7 CrTTM-Standalone Results
Price/Sales5.41xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for KREBS BIOCHEMICALS & INDUSTRIES
Please provide your vote to see the results
KREBS BIOCHEMICALS & INDUSTRIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of KREBS BIOCHEMICALS & INDUSTRIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of KREBS BIOCHEMICALS & INDUSTRIES is calculated as :

Current Market Cap [ ₹128.3 Cr] as on Jul 03,2026

(/) Sales [ ₹23.7 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 5.41x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for KREBS BIOCHEMICALS & INDUSTRIES , the investors are currently willing to pay '5.41 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of KREBS BIOCHEMICALS & INDUSTRIES !

The chart below summarizes the trend in P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES over the last five years.

Historical PS (Price/Sales) ratio chart of KREBS BIOCHEMICALS & INDUSTRIES


PS Ratio Performance Analysis for KREBS BIOCHEMICALS & INDUSTRIES

- KREBS BIOCHEMICALS & INDUSTRIES 's latest p/e ratio is 5.41x.

- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.34x.

- KREBS BIOCHEMICALS & INDUSTRIES 's operated at median p/e ratio of 3.25x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio peaked in Mar2022 at 5.18x.

- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio hit its five-year low in Mar2023 of 2.33x.


How does KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
KREBS BIOCHEMICALS & INDUSTRIES 23.75.41128.3
SUN PHARMACEUTICAL INDUSTRIES LTD58,462.07.82456,989.0
DIVIS LABORATORIES LTD10,560.017.00179,471.0
TORRENT PHARMACEUTICALS LTD13,980.011.54161,290.0
CIPLA LTD28,162.64.18117,820.0
DR REDDYS LABORATORIES LTD33,700.23.40114,730.0
MANKIND PHARMA LTD14,277.67.32104,535.0
LUPIN LTD27,958.04.05113,215.0
ZYDUS LIFESCIENCES LTD27,148.44.19113,815.0
AUROBINDO PHARMA LTD33,653.12.7793,217.0
LAURUS LABS LTD6,812.912.2383,293.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.77x
Max industry PS 17.00x
Median industry PS 5.41x
Average industry PS 7.26x



You may also like the below Video Courses